tiprankstipranks
Trending News
More News >
NLS Pharmaceutics (NLSP)
NASDAQ:NLSP
US Market

NLS Pharmaceutics (NLSP) Technical Analysis

Compare
271 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
6Neutral
7Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
NLS Pharmaceutics’s (NLSP) Moving Averages Convergence Divergence (MACD) indicator is 0.19, suggesting NLS Pharmaceutics is a Sell.
NLS Pharmaceutics’s (NLSP) 20-Day exponential moving average is 2.16, while NLS Pharmaceutics’s (NLSP) share price is $2.28, making it a Buy.
NLS Pharmaceutics’s (NLSP) 50-Day exponential moving average is 1.93, while NLS Pharmaceutics’s (NLSP) share price is $2.28, making it a Buy.

NLS Pharmaceutics (NLSP) Pivot Points

Jun 16, 2025, 04:49 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.11
2.21
2.30
2.39
2.48
2.58
2.67
Fibonacci
2.21
2.28
2.32
2.39
2.46
2.51
2.58
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

NLS Pharmaceutics (NLSP) Moving Averages

Jun 16, 2025, 04:49 PM
Period
Simple
Exponential
MA5
2.48Sell
2.37Sell
MA10
2.30Sell
2.31Sell
MA20
2.13Buy
2.16Buy
MA50
1.76Buy
1.93Buy
MA100
1.79Buy
2.11Buy
MA200
2.81Sell
3.34Sell
NLS Pharmaceutics’s (NLSP) 10-Day exponential moving average is 2.31, while NLS Pharmaceutics’s (NLSP) share price is $2.28, making it a Sell.
NLS Pharmaceutics’s (NLSP) 100-Day exponential moving average is 2.11, while NLS Pharmaceutics’s (NLSP) share price is $2.28, making it a Buy.
NLS Pharmaceutics’s (NLSP) stock price is $2.28 and NLS Pharmaceutics’s (NLSP) 50-day simple moving average is 1.76, creating a Buy signal.
NLS Pharmaceutics’s (NLSP) stock price is $2.28 and NLS Pharmaceutics’s (NLSP) 100-day simple moving average is 1.79, creating a Buy signal.
NLS Pharmaceutics’s (NLSP) stock price is $2.28 and NLS Pharmaceutics’s (NLSP) 200-day simple moving average is 2.81, creating a Sell signal.

NLS Pharmaceutics (NLSP) Technical Indicators

Jun 16, 2025, 04:49 PM
Name
Value
Implied Action
RSI (14)
56.41
Neutral
STOCH (9,6)
48.61
Neutral
STOCHRSI (14)
54.78
Neutral
MACD (12,26)
0.19
Sell
ADX (14)
35.25
Neutral
Williams %R
-55.77
Buy
CCI (14)
45.27
Neutral
ATR (14)
0.22
-
Ultimate Oscillator
60.14
Neutral
ROC
23.24
Buy
NLS Pharmaceutics’s (NLSP) Relative Strength Index (RSI) is 56.41, creating a Neutral signal.
NLS Pharmaceutics’s (NLSP) Trend Strength Indicator (ADX) is 35.25, creating a Neutral signal.
NLS Pharmaceutics’s (NLSP) Commodity Channel Index (CCI) is 45.27, creating a Neutral signal.
NLS Pharmaceutics’s (NLSP) Price Rate of Change (ROC) is 23.24, creating a Buy signal.

FAQ

Is NLSP a Buy, Hold, or Sell?
Based on NLSP’s technical indicators, NLSP is a Hold.
    What is NLSP’s RSI (14)?
    NLSP’s RSI (14) is 56.41, which suggests NLSP is a Neutral.
      What is NLSP’s MACD?
      NLSP’s MACD is 0.19, which suggests NLSP is a Sell.
        What is NLSP’s 5-day moving average?
        NLSP’s 5-day moving average is 2.48, which suggests NLSP is a Sell.
          What is NLSP’s 20-day moving average?
          NLSP 20-day moving average is 2.13, which suggests NLSP is a Buy.
            What is NLSP’s 50-day moving average?
            NLSP’s 50-day moving average is 1.76, which suggests NLSP is a Buy.
              What is NLSP’s 200-day moving average?
              NLSP’s 200-day moving average is 2.81, which suggests NLSP is a Sell.
                What is NLSP’s Williams % R (14)?
                NLSP’s Williams % R (14) is -55.77, which suggests NLSP is a Buy.
                  What is NLSP’s CCI (14)?
                  NLSP’s CCI (14) is 45.27, which suggests NLSP is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis